D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
National Vision
EYE
$1.76B
| $3.17M | ﹤0.01% |
55,868
-118,243
| -68% | -$6.53M |
|
2427
Viavi Solutions
VIAV
$7.95B
| $3.17M | ﹤0.01% |
201,444
+183,168
| +1,002% | +$3M |
|
|
EUSG
2428
DELISTED
European Sustainable Growth Acquisition Corp. Class A Ordinary Shares
EUSG
| $3.16M | ﹤0.01% |
318,543
+147,952
| +87% | +$1.45M |
|
2429
Integra LifeSciences
IART
$1.28B
| $3.15M | ﹤0.01% |
46,044
-44,190
| -49% | -$3.12M |
|
|
GTPB
2430
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
| $3.15M | ﹤0.01% |
322,408
+222,408
| +222% | +$2.18M |
|
2431
Dave Inc
DAVE
$4.82B
| $3.15M | ﹤0.01% |
9,933
+7,850
| +377% | +$2.49M |
|
2432
CALL
Acuity Brands
AYI
$9.99B
| $3.14M | ﹤0.01% |
18,100
| – | – |
|
2433
Independent Bank Corp
IBCP
$796M
| $3.13M | ﹤0.01% |
145,899
-1,374
| -0.9% | -$28.6K |
|
|
PBCT
2434
DELISTED
People's United Financial Inc
PBCT
| $3.13M | ﹤0.01% |
179,348
-157,306
| -47% | -$2.56M |
|
2435
Planet Labs
PL
$6.94B
| $3.13M | ﹤0.01% |
315,934
+249,441
| +375% | +$2.47M |
|
2436
Emergent Biosolutions
EBS
$379M
| $3.13M | ﹤0.01% |
62,445
+52,852
| +551% | +$3.2M |
|
2437
ProKidney
PROK
$316M
| $3.13M | ﹤0.01% |
319,035
+219,035
| +219% | +$2.16M |
|
|
MACQ
2438
DELISTED
MCAP Acquisition Corporation Class A Common Stock
MACQ
| $3.13M | ﹤0.01% |
+316,760
| New | +$3.1M |
|
|
PRST
2439
DELISTED
Presto Technologies, Inc. Common Stock
PRST
| $3.13M | ﹤0.01% |
312,801
+204,357
| +188% | +$2.03M |
|
2440
Coty
COTY
$2.4B
| $3.12M | ﹤0.01% |
397,467
-1,312,143
| -77% | -$11.2M |
|
2441
NXP Semiconductors
NXPI
$60.8B
| $3.12M | ﹤0.01% |
15,933
+5,088
| +47% | +$1.06M |
|
2442
Minerals Technologies
MTX
$2.29B
| $3.12M | ﹤0.01% |
44,599
+38,321
| +610% | +$2.93M |
|
|
LSI
2443
DELISTED
Life Storage, Inc.
LSI
| $3.11M | ﹤0.01% |
27,119
-42,325
| -61% | -$5.03M |
|
2444
The Ensign Group
ENSG
$10.6B
| $3.11M | ﹤0.01% |
41,547
+37,013
| +816% | +$3.06M |
|
2445
Atlantic Union Bankshares
AUB
$6.05B
| $3.11M | ﹤0.01% |
84,406
+3,763
| +5% | +$135K |
|
|
DNZ
2446
DELISTED
D and Z Media Acquisition Corp.
DNZ
| $3.11M | ﹤0.01% |
319,541
+97,683
| +44% | +$946K |
|
2447
Theravance Biopharma
TBPH
$873M
| $3.11M | ﹤0.01% |
+420,051
| New | +$4.7M |
|
|
SFIX
2448
CALL
Stitch Fix
SFIX
$567M
| $3.1M | ﹤0.01% |
77,700
-30,000
| -28% | -$1.4M |
|
2449
World Acceptance Corp
WRLD
$861M
| $3.1M | ﹤0.01% |
16,373
+91
| +0.6% | +$16.8K |
|
2450
PUT
PagSeguro Digital
PAGS
$2.67B
| $3.1M | ﹤0.01% |
60,000
-10,000
| -14% | -$561K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.